{"symbol": "AUPH", "companyName": "Aurinia Pharmaceuticals Inc", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.auriniapharma.com", "description": "Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The firm is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.", "CEO": "Richard M. Glickman", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}